Immunogenicity and safety of an intradermal fractional third dose of ChAdOx1 nCoV-19/AZD1222 vaccine compared with those of a standard intramuscular third dose in volunteers who previously received two doses of CoronaVac: A randomized controlled trial-Reference-Cited by-同舟云学术

Immunogenicity and safety of an intradermal fractional third dose of ChAdOx1 nCoV-19/AZD1222 vaccine compared with those of a standard intramuscular third dose in volunteers who previously received two doses of CoronaVac: A randomized controlled trial

Published:2022-03 Issue:12 Volume:40 Page:1761-1767
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Tawinprai Kriangkrai^ORCID,Siripongboonsitti Taweegrit^ORCID,Porntharukchareon Thachanun^ORCID,Wittayasak Kasiruck,Thonwirak Nawarat,Soonklang Kamonwan,Sornsamdang Gaidganok,Auewarakul Chirayu^ORCID,Mahanonda Nithi

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference37 articles.

1. World Health Organization. WHO coronavirus (COVID-19) dashboard 2021, https://covid19.who.int/table; 2021 [accessed 17 September 2021].

2. Repurposed antiviral drugs for COVID-19 – interim WHO Solidarity Trial results;WHO Solidarity Trial Consortium;N Engl J Med,2021

3. COVID-19 vaccine efficacy and effectiveness – the elephant (not) in the room;Olliaro;Lancet Microbe,2021

4. Adaptive immunity to SARS-CoV-2 and COVID-19;Sette;Cell,2021

5. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey;Tanriover;Lancet,2021

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relative vaccine effectiveness of ChAdOx1/AZD1222 vaccines as booster dose via intradermal injection with a one-fifth dose compared with the intramuscular injection in the prevention of SAR-CoV-2 infections in Phuket: A retrospective cohort study;International Journal of Infectious Diseases;2024-10

2. Clinical perspective on topical vaccination strategies;Advanced Drug Delivery Reviews;2024-05

3. Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine: safety and immunogenicity of a fractional booster dose;Clinical Microbiology and Infection;2024-03

4. Immunogenicity of Intradermal Versus Intramuscular BNT162b2 COVID-19 Booster Vaccine in Patients with Immune-Mediated Dermatologic Diseases: A Non-Inferiority Randomized Controlled Trial;Vaccines;2024-01-11

5. Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults;Human Vaccines & Immunotherapeutics;2023-07-12